Cytosorbents
CTSO
#11202
Rank
C$1.53 M
Marketcap
C$0.49
Share price
0.03%
Change (1 day)
-60.55%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -C$16.99 Million

According to Cytosorbents's latest financial reports the company's current earnings are C$37.2 Million. In 2025 the company made an earning of -C$12.03 Million, an increase over its 2024 earnings that were of -C$31.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$16.99 Million41.18%
2025 -C$12.03 Million-62.16%
2024 -C$31.79 Million-22.49%
2023 -C$41.02 Million-13.52%
2022 -C$47.43 Million34.04%
2021 -C$35.38 Million182.17%
2020 -C$12.54 Million-55.97%
2019 -C$28.48 Million14.17%
2018 -C$24.94 Million95.14%
2017 -C$12.79 Million-22.32%
2016 -C$16.46 Million39.1%
2015 -C$11.83 Million-12.89%
2014 -C$13.58 Million89%
2013 -C$7.19 Million26.65%
2012 -C$5.68 Million-26.02%
2011 -C$7.67 Million-288.45%
2010 C$4.06 M-4.17%
2009 C$4.24 M-287.19%
2008 -C$2.27 Million-47.12%
2007 -C$4.29 Million41.78%
2006 -C$3.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
C$5.23 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
C$1.08 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
C$77.63 M-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA